Indoco Remedies Limited (NSE:INDOCO) — Market Cap & Net Worth

$240.62 Million USD · Rs22.25 Billion INR · Rank #15906

Market Cap & Net Worth: Indoco Remedies Limited (INDOCO)

Indoco Remedies Limited (NSE:INDOCO) has a market capitalization of $240.62 Million (Rs22.25 Billion) as of September 17, 2026. Listed on the NSE stock exchange, this India-based company holds position #15906 globally and #804 in its home market, demonstrating a -8.05% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Indoco Remedies Limited's stock price Rs241.39 by its total outstanding shares 92173705 (92.17 Million). Also see how large is Indoco Remedies Limited's balance sheet for a full breakdown of the balance sheet.

Indoco Remedies Limited Market Cap History: 2015 to 2026

Indoco Remedies Limited's market capitalization history from 2015 to 2026. Data shows change from $314.27 Million to $240.62 Million (-2.34% CAGR). Also see Indoco Remedies Limited (INDOCO) cash flow conversion for how efficiently the company converts equity into cash flow.

Index Memberships

Indoco Remedies Limited is a constituent of 2 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
NIFTY MICROCAP 250 NIFTYMICROCAP250	$151.69 Billion	0.16%	#164 of 250
NIFTY TOTAL MARKET NIFTYTOTALMKT	$3.13 Trillion	0.01%	#550 of 750

Weight: Indoco Remedies Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Indoco Remedies Limited Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Indoco Remedies Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check today's stock price for Indoco Remedies Limited for real-time trading data and today's change.

Latest Price to Sales (P/S) Ratio

0.01x

Indoco Remedies Limited's market cap is 0.01 times its annual revenue

Industry average: 0.56x Lower than industry average

Latest Price to Earnings (P/E) Ratio

N/A

P/E ratio not applicable due to negative or zero earnings

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2017	$273.12 Million	$10.97 Billion	$770.61 Million	0.02x	0.35x
2018	$211.87 Million	$10.18 Billion	$411.61 Million	0.02x	0.51x
2019	$187.80 Million	$9.42 Billion	-$29.04 Million	0.02x	N/A
2020	$298.42 Million	$10.80 Billion	$241.17 Million	0.03x	1.24x
2021	$447.30 Million	$12.19 Billion	$930.46 Million	0.04x	0.48x
2022	$401.21 Million	$15.04 Billion	$1.55 Billion	0.03x	0.26x
2023	$392.35 Million	$16.40 Billion	$1.42 Billion	0.02x	0.28x
2024	$331.14 Million	$17.88 Billion	$984.60 Million	0.02x	0.34x
2025	$233.85 Million	$16.65 Billion	-$737.40 Million	0.01x	N/A
2026	$240.62 Million	$18.45 Billion	-$987.00 Million	0.01x	N/A

Competitor Companies of INDOCO by Market Capitalization

Companies near Indoco Remedies Limited in the global market cap rankings as of September 17, 2026. Review how tangible is Indoco Remedies Limited's equity to assess the quality of the company's equity after excluding intangible assets.

Key companies related to Indoco Remedies Limited by market ranking:

Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #518 globally with a market cap of $52.60 Billion USD.
Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #631 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
GALDERMA GROUP AG (NYSE:GALDY): Ranked #636 globally with a market cap of $43.34 Billion USD.
Haleon plc (NYSE:HLN): Ranked #672 globally with a market cap of $40.69 Billion USD.

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#518	Takeda Pharmaceutical Co Ltd ADR	NYSE:TAK	$52.60 Billion	$16.65
#631	Takeda Pharmaceutical Company Limited	F:TKDA	$43.60 Billion	€16.00
#636	GALDERMA GROUP AG	NYSE:GALDY	$43.34 Billion	$37.18
#672	Haleon plc	NYSE:HLN	$40.69 Billion	$9.24

Indoco Remedies Limited Historical Marketcap From 2015 to 2026

Between 2015 and today, Indoco Remedies Limited's market cap moved from $314.27 Million to $ 240.62 Million, with a yearly change of -2.34%.

Year	Market Cap	Change (%)
2026	Rs240.62 Million	+2.89%
2025	Rs233.85 Million	-29.38%
2024	Rs331.14 Million	-15.60%
2023	Rs392.35 Million	-2.21%
2022	Rs401.21 Million	-10.30%
2021	Rs447.30 Million	+49.89%
2020	Rs298.42 Million	+58.90%
2019	Rs187.80 Million	-11.36%
2018	Rs211.87 Million	-22.42%
2017	Rs273.12 Million	+8.48%
2016	Rs251.76 Million	-19.89%
2015	Rs314.27 Million	--

End of Day Market Cap According to Different Sources

On Sep 16th, 2026 the market cap of Indoco Remedies Limited was reported to be:

Source	Market Cap
Yahoo Finance	$240.62 Million USD
MoneyControl	$240.62 Million USD
MarketWatch	$240.62 Million USD
marketcap.company	$240.62 Million USD
Reuters	$240.62 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Indoco Remedies Limited

NSE:INDOCO India Drug Manufacturers - Specialty & Generic

Market Cap

$240.62 Million

Rs22.25 Billion INR

Market Cap Rank

#15906 Global

#804 in India

Share Price

Rs241.39

Change (1 day)

-8.22%

52-Week Range

Rs164.00 - Rs302.45

All Time High

Rs511.66